Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
CHICAGO Use of GLP-1 diabetes and weight-loss medications will climb through the rest of this decade and continue to change the way US consumers eat and buy food and beverages, according to new research from Circana
The prescribing provider should carefully evaluate concurrent medications and adjust dosing as appropriate for the individual patient
One popular example of a real-world GLP-1 agonist is Ozempic
A patient with BMI 35 or higher would also meet Tier 1 by BMI alone
These generally improve as the body adjusts or when the dose is increased gradually
US$ 29.26
US$ 26.08
US$ 21.92
